근접방사선치료 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Brachytherapy Market size is expected to reach USD 2.29 Billion in 2034 from USD 1.17 Billion (2025) growing at a CAGR of 7.72% during 2026-2034.

The brachytherapy market is experiencing significant growth, driven by the increasing prevalence of cancer and the demand for targeted treatment options. Brachytherapy, a form of radiation therapy that involves placing radioactive sources directly within or near a tumor, offers several advantages over traditional external beam radiation therapy, including reduced exposure to surrounding healthy tissues and improved treatment precision. As healthcare providers seek to enhance patient outcomes and minimize side effects, the adoption of brachytherapy is expected to rise, positioning this market for robust expansion. The growing body of clinical evidence supporting the efficacy of brachytherapy in treating various cancers, including prostate, breast, and cervical cancers, is further fueling this trend.

Moreover, advancements in brachytherapy technologies are driving innovation within the market. The development of new radioactive isotopes, improved delivery systems, and advanced imaging techniques is enhancing the effectiveness and safety of brachytherapy procedures. These innovations not only improve treatment outcomes but also contribute to a more streamlined workflow for healthcare providers. As research continues to explore new applications for brachytherapy, such as in combination with immunotherapy and other treatment modalities, the market is likely to expand further, driven by the promise of improved patient care and outcomes.

Additionally, the growing emphasis on personalized medicine is shaping the brachytherapy landscape. As healthcare providers increasingly seek to tailor treatments to individual patients, the demand for flexible and adaptable brachytherapy solutions is likely to rise. This trend is particularly relevant in the context of advanced cancer treatments, where understanding the specific characteristics of a tumor can significantly impact treatment decisions. As the brachytherapy market continues to evolve, the convergence of technological advancements, personalized treatment approaches, and a focus on improving patient outcomes will play a crucial role in driving its future growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Dosage Type

• High-Dose Rate (HDR) Brachytherapy
• Low-Dose Rate (LDR) Brachytherapy

By Product

• Seeds
• Applicators & Afterloaders
• Electronic Brachytherapy

By Application

• Prostate Cancer
• Gynaecological Cancer
• Breast Cancer
• Others

COMPANIES PROFILED

• Varian Medical Systems Inc, Becton, Dickinson Company, Elekta AB, Isoray Medical Inc, Eckert Ziegler BEBIG, iCAD Inc, CIVCO Medical Solutions, Theragenics Corporation

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BRACHYTHERAPY MARKET: BY DOSAGE TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Dosage Type
• 4.2. High-Dose Rate (HDR) Brachytherapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Low-Dose Rate (LDR) Brachytherapy Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BRACHYTHERAPY MARKET: BY PRODUCT 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Product
• 5.2. Seeds Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Applicators & Afterloaders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Electronic Brachytherapy Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BRACHYTHERAPY MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Prostate Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Gynaecological Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Breast Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BRACHYTHERAPY MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Dosage Type
  • 7.2.2 By Product
  • 7.2.3 By Application
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Dosage Type
  • 7.3.2 By Product
  • 7.3.3 By Application
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Dosage Type
  • 7.4.2 By Product
  • 7.4.3 By Application
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Dosage Type
  • 7.5.2 By Product
  • 7.5.3 By Application
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Dosage Type
  • 7.6.2 By Product
  • 7.6.3 By Application
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL BRACHYTHERAPY INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Varian Medical Systems Inc
  • 9.2.2 Becton
  • 9.2.3 Dickinson & Company
  • 9.2.4 Elekta AB
  • 9.2.5 Isoray Medical Inc
  • 9.2.6 Eckert & Ziegler BEBIG
  • 9.2.7 ICAD Inc
  • 9.2.8 CIVCO Medical Solutions
  • 9.2.9 Theragenics Corporation